Results 341 to 350 of about 1,072,475 (388)

Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction. [PDF]

open access: yesOpen Heart
Arai M   +22 more
europepmc   +1 more source

Usefulness of serial N-terminal pro-B-type natriuretic peptide values after biventricular repair in patients with borderline hypoplastic left ventricle. [PDF]

open access: yesInterdiscip Cardiovasc Thorac Surg
Osawa T   +12 more
europepmc   +1 more source

Cardiac natriuretic peptides

Nature Reviews Cardiology, 2020
Investigations into the mixed muscle-secretory phenotype of cardiomyocytes from the atrial appendages of the heart led to the discovery that these cells produce, in a regulated manner, two polypeptide hormones - the natriuretic peptides - referred to as atrial natriuretic factor or atrial natriuretic peptide (ANP) and brain or B-type natriuretic ...
Tsuneo Ogawa   +6 more
openaire   +4 more sources

Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

European Journal of Heart Failure, 2023
Natriuretic peptides, brain (B‐type) natriuretic peptide (BNP) and N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) are globally and most often used for the diagnosis of heart failure (HF).
H. Tsutsui   +27 more
semanticscholar   +1 more source

The natriuretic peptide family

Current Opinion in Nephrology and Hypertension, 1993
The natriuretic peptide system is a complicated system comprising at least three endogenous peptides (atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide) and three receptors [the atrial natriuretic peptide-A receptor (guanylyl cyclase A), the atrial natriuretic peptide-B receptor (guanylyl cyclase B) and the clearance ...
Yoshihiro Ogawa   +4 more
openaire   +4 more sources

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Endocrinology, 1992
To elucidate the ligand-receptor relationship of the natriuretic peptide system, which comprises at least three endogenous ligands, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), and three receptors, the ANP-A receptor or guanylate cyclase-A (GC-A), the ANP-B receptor or guanylate cyclase-B (GC ...
Hiroshi Arai   +9 more
openaire   +2 more sources

Biology of the Natriuretic Peptides

The American Journal of Cardiology, 2008
The biology of the natriuretic peptide (NP) system is complex, yet highly phylogenetically preserved. It regulates salt and water handling, promotes vasodilatation, and exerts favorable effects on the heart in the context of processes such as heart failure.
James L. Januzzi   +3 more
openaire   +3 more sources

The natriuretic peptides

Basic Research in Cardiology, 2004
The natriuretic peptides are a family of widely distributed, but evolutionarily conserved, polypeptide mediators that exert a range of actions throughout the body. In cardiovascular homeostasis, the endocrine roles of the cardiac-derived atrial and B-type natriuretic peptide (ANP and BNP) in regulating central fluid volume and blood pressure have been ...
openaire   +2 more sources

Natriuretic peptides and hypertension

Current Opinion in Nephrology and Hypertension, 1996
Natriuretic peptides are produced in the brain, heart and vasculature, and cause vasodilation, sodium excretion, and diuresis. Recent advances indicate that they play important roles in blood-pressure homeostasis, both in normal and in pathophysiological conditions.
Elzbieta Biesiada   +2 more
openaire   +3 more sources

Natriuretic Peptides in ESRD

American Journal of Kidney Diseases, 2005
Natriuretic peptides are involved in the regulation of volume homeostasis. Their levels generally are increased in the setting of volume expansion and act on multiple effector systems to cause vasodilation and natriuresis in an effort to return volume status back to normal. In patients with end-stage renal disease, the natriuretic capabilities of these
Mitchell H. Rosner, Sergei Joffy
openaire   +3 more sources

Home - About - Disclaimer - Privacy